서린바이오: insider trades · South Korea · DART (FSS)

Discover the full management transaction log of 서린바이오, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 서린바이오 has recorded 1 public disclosures. Market capitalisation: €51.7bn. The latest transaction was reported on 2 April 2026 (Purchase). Among the most active insiders: 강미옥. Every trade is openly available.